Cognex (CGNX) PT Set at $80.00 by Deutsche Bank

Cognex (NASDAQ:CGNX) has been assigned a $80.00 target price by stock analysts at Deutsche Bank in a report released on Friday, Marketbeat Ratings reports. The brokerage currently has a “buy” rating on the scientific and technical instruments company’s stock. Deutsche Bank’s price target points to a potential upside of 15.84% from the stock’s current price.

Several other brokerages also recently weighed in on CGNX. ValuEngine downgraded Cognex from a “hold” rating to a “sell” rating in a research report on Thursday, December 7th. Canaccord Genuity upped their price objective on Cognex from $47.50 to $60.00 and gave the stock a “hold” rating in a research report on Tuesday, October 31st. BidaskClub upgraded Cognex from a “hold” rating to a “buy” rating in a research report on Wednesday, January 10th. Zacks Investment Research upgraded Cognex from a “hold” rating to a “buy” rating and set a $69.00 price objective for the company in a research report on Wednesday, November 1st. Finally, Robert W. Baird upped their price objective on Cognex from $50.00 to $62.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 31st. Three research analysts have rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company’s stock. Cognex has an average rating of “Hold” and a consensus target price of $63.00.

Shares of Cognex (CGNX) opened at $69.06 on Friday. The firm has a market capitalization of $11,960.00, a price-to-earnings ratio of 50.78 and a beta of 1.50. Cognex has a 1 year low of $32.05 and a 1 year high of $72.99.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings data on Monday, October 30th. The scientific and technical instruments company reported $0.57 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.05. Cognex had a return on equity of 23.31% and a net margin of 34.77%. The business had revenue of $259.74 million during the quarter, compared to the consensus estimate of $255.95 million. During the same period in the prior year, the company earned $0.31 EPS. Cognex’s revenue for the quarter was up 75.6% on a year-over-year basis. equities analysts expect that Cognex will post 1.39 EPS for the current year.

In other Cognex news, Director Jeffrey Benjamin Miller sold 7,500 shares of the stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $124.23, for a total value of $931,725.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Patrick Alias sold 5,000 shares of the stock in a transaction dated Monday, November 27th. The shares were sold at an average price of $143.54, for a total value of $717,700.00. The disclosure for this sale can be found here. Insiders sold 143,750 shares of company stock valued at $18,540,975 over the last quarter. Corporate insiders own 5.60% of the company’s stock.

A number of institutional investors have recently bought and sold shares of the business. Winslow Evans & Crocker Inc. raised its position in Cognex by 60.8% in the fourth quarter. Winslow Evans & Crocker Inc. now owns 6,968 shares of the scientific and technical instruments company’s stock valued at $426,000 after purchasing an additional 2,634 shares during the last quarter. Wealth Enhancement Advisory Services LLC acquired a new stake in shares of Cognex in the fourth quarter valued at about $1,079,000. GW&K Investment Management LLC increased its stake in shares of Cognex by 38.9% in the fourth quarter. GW&K Investment Management LLC now owns 473,614 shares of the scientific and technical instruments company’s stock valued at $28,966,000 after buying an additional 132,562 shares during the period. State of Alaska Department of Revenue acquired a new stake in shares of Cognex in the fourth quarter valued at about $746,000. Finally, Oakbrook Investments LLC increased its stake in shares of Cognex by 99.7% in the fourth quarter. Oakbrook Investments LLC now owns 14,680 shares of the scientific and technical instruments company’s stock valued at $898,000 after buying an additional 7,330 shares during the period. Hedge funds and other institutional investors own 42.10% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This report was originally published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this report on another publication, it was stolen and republished in violation of United States & international copyright & trademark laws. The original version of this report can be viewed at https://sportsperspectives.com/2018/01/21/cognex-cgnx-pt-set-at-80-00-by-deutsche-bank.html.

Cognex Company Profile

Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.

Analyst Recommendations for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply